Blood Test May Help Identify Which Colon Cancer Patients Benefit from NSAIDS Based on Data from Alliance Research

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology. Based on data from an Alliance for Clinical Trials in Oncology study, this finding could lead to more personalized treatments and better outcomes for patients.

Colon cancer is one of the most common cancers in the United States with about 110,000 new cases diagnosed each year, according to the Am

• Read more